| abstract |
The invention relates to a cell-free combination for use - in the controlled, more particularly decelerated or delayed, active agent release and/or - in the production of a formulation in hydrogel form, more particularly a depot formulation in hydrogel form, and/or - as a formulation in hydrogel form, more particularly a depot formulation in hydrogel form and/or - for coating a medical product, more particularly an implant, preferably with a formulation in hydrogel form, more particularly a depot formulation in hydrogel form, wherein the cell-free combination has a first component and a second component, wherein the first component contains albumin that can be crosslinked and the second component contains a crosslinking agent for the albumin. The invention further relates to a material forming a hydrogel or a hydrogel, a kit or multi-component system, a medical product or pharmaceutical formulation, a discharge device and uses of the cell-free combination and of the material forming a hydrogel or the hydrogel. |